Ferrata Storti Foundation

SHERPA: Unknown

People

  1. Levine
    Levine
  2. Zelenetz
    Zelenetz
  3. Mauro
    Mauro
  4. Abdel-Wahab
    Abdel-Wahab
  5. Dogan
    Dogan
  6. Horwitz
    Horwitz
  7. Perales
    Perales
  8. Salles
    Salles
  9. Giralt
    Giralt
  10. Tallman
    Tallman

Groups

  1. Department of Medicine (292)
  2. Hematologic Malignancies, Division of (290)
  3. Center for Hematologic Malignancies (268)
  4. Adult Leukemia (105)
  5. Lymphoma (73)
  6. GSK Faculty (70)
  7. Executive Committee, Center for Hematologic Malignancies (60)
  8. Hematologic Malignancies Research (45)
  9. Sloan Kettering Institute Postdocs (43)
  10. Myeloma (41)
Search Within
Formats
  1. Meeting Abstract (178)
  2. Journal Article (124)
  3. Research Letter (24)
  4. Editorial (15)
  5. Review (9)
  6. Correspondence (1)
  7. Guidelines (1)
Groups
  1. Department of Medicine (292)
  2. Hematologic Malignancies, Division of (290)
  3. Center for Hematologic Malignancies (268)
  4. Adult Leukemia (105)
  5. Lymphoma (73)
  6. GSK Faculty (70)

More Groups

People
  1. Carl Landgren (25)
  2. Andrew Zelenetz (24)
  3. Martin Tallman (24)
  4. Ross Levine (24)
  5. Michael Mauro (21)
  6. Anas Younes (16)

More People

Years
  1. 2025 (12)
  2. 2024 (23)
  3. 2023 (17)
  4. 2022 (20)
  5. 2021 (13)
  6. 2020 (18)

More Years

Publications
  1. Haematologica (348)
  2. Haematologica Meeting Reports (4)

Results (352)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dexamethasone is associated with reduced frequency and intensity of cytokine release syndrome compared with alternative corticosteroid regimens as premedication for glofitamab in patients with relapsed/refractory large B-cell lymphoma
    Journal Article

    Falchi, L.; Hutchings, M.; Carlo-Stella, C.; Morschhauser, F.; Dickinson, M.; Cartron, G.; Khan, C.; Tani, M.; Martinez-Lopez, J.; Bartlett, N. L.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Prevention and treatment of transformation of myeloproliferative neoplasms to acute myeloid leukemia
    Journal Article

    Patel, A. A.; Rampal, R. K.
    Haematologica (2025)

    Fulltext@MSK | Save
  • Early death and intracranial hemorrhage prediction in acute promyelocytic leukemia: Validation of a risk score in a cohort from an international consortium treated with chemotherapy plus all-trans retinoic acid
    Research Letter

    Silva, W. F.; Kim, H. T.; Undurraga, M. S.; Navarro-Cabrera, J. R.; Salinas, V.; Muxi, P.; Melo, R. A. M.; Gloria, A. B. F.; Pagnano, K. B. B.; Nunes, E. C.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Belantamab mafodotin monotherapy for relapsed or refractory multiple myeloma: A real-world observational study in the United States
    Research Letter

    Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Delforge, M.; Kotowsky, N.; Bitetti, J.; Boytsov, N.; Camadoo-O’Byrne, L.; Happ, L. P.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Loncastuximab in high-risk and heavily pretreated relapsed/refractory diffuse large B-cell lymphoma: A real-world analysis from 21 US centers
    Journal Article

    Zelikson, V.; Gurumurthi, A.; Sawalha, Y.; Annunzio, K.; Saha, A.; Dong, N.; Qualls, D.; Amoozgar, B.; Kahl, B.; Baird, J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Predictors and implications of renal injury after CD19 chimeric antigen receptor T-cell therapy
    Journal Article

    Boardman, A. P.; Gutgarts, V.; Flynn, J. R.; Devlin, S. M.; Goldman, A.; Tomas, A. A.; Fein, J. A.; Slingerland, J. B.; Parascondola, A.; Lin, R. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Polytypic B cells, monotypic/monoclonal B-cell proliferations, and neoplastic T cells diverge from TET2-/ DNMT3A-mutant clonal hematopoiesis in follicular helper T-cell lymphomas
    Research Letter

    Lewis, N. E.; Petrova-Drus, K.; Sardana, R.; Huet, S.; Gao, Q.; Sethi, S.; Vanderbilt, C.; Xiao, W.; Roshal, M.; Baik, J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Evaluating serum free light chain ratio as a biomarker in multiple myeloma
    Journal Article

    Akhlaghi, T.; Maclachlan, K.; Korde, N.; Mailankody, S.; Lesokhin, A. M.; Hassoun, H.; Lu, S. X.; Patel, D.; Shah, U. A.; Tan, C. R.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Rituximab and lenalidomide for the treatment of relapsed or refractory indolent non-Hodgkin lymphoma: Real-life experience
    Journal Article

    Cassanello, G.; Drill, E.; Rivas-Delgado, A.; Okwali, M.; Isgor, I.; Caron, P. C.; Epstein-Peterson, Z.; Ghione, P.; Hamlin, P. A.; Lue, J. K.; more...
    Haematologica (2025)

    Fulltext@MSK | Save
  • Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: Results of the phase I/II BRUIN trial
    Journal Article

    Shah, N. N.; Wang, M.; Roeker, L. E.; Patel, K.; Woyach, J. A.; Wierda, W. G.; Ujjani, C. S.; Eyre, T. A.; Zinzani, P. L.; Alencar, A. J.; more...
    Haematologica (2025)

    Fulltext@MSK | Save

    • Ferrata Storti Foundation – authorized name for: